MAYNE Pharma today confirmed it had been served with a class action proceeding in the Supreme Court of Vic.
The proceeding is being brought on behalf of anyone who acquired Mayne shares between 24 Nov 2014 and 15 Dec 2016, alleging misleading or deceptive conduct and breaches of continuous disclosure obligations relating to allegations of anti-competitive conduct in the US.
An American investigation of the claims led to a significant drop in the Mayne share price.
The company said it would vigorously defend the proceeding, saying it "emphatically denies any and all allegations of wrongdoing".
The above article was sent to subscribers in Pharmacy Daily's issue from 03 Aug 21
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Aug 21
